Related Experiment Video

Updated: Dec 14, 2025

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry
10:58

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

5.4K

Correction to "A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric

Saktimayee M Roy, George Minasov, Ottavio Arancio

    Journal of Medicinal Chemistry
    |July 17, 2020
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke12:01

    PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

    Published on: June 14, 2018

    13.1K
    Lipidomics and Transcriptomics in Neurological Diseases09:58

    Lipidomics and Transcriptomics in Neurological Diseases

    Published on: March 18, 2022

    3.8K

    Related Concept Videos

    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

    Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

    Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
    430